The polysulfonated compound suramin blocks adsorption and lateral difusion of herpes simplex virus type-1 in vero cells

Virology

Volumn 258, Issue 1, 1999, Pages 141-151

  Aguilar, José S ^a   Rice, Marcia ^a   Wagner, Edward K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; HEPARIN; SURAMIN;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; HERPES SIMPLEX VIRUS 1; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VERO CELL; VIRUS ADSORPTION; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0033602699     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9723     Document Type: Article

References (42)

1. Alarcón B., Lacal J. C., Fernández-Sousa J. M., Carrasco L. Screening for new compounds with antiherpes activity. Antiviral Res. 4:1984;231-243.
2. Alzani R., Corti A., Grazioli L., Cozzi E., Ghezzi P., Marcucci F. Suramin induces deoligomerization of human tumor necrosis factor alpha. J. Biol. Chem. 268:1993;12526-12529.
3. Bailey, N. T. J. 1995, Statistical Methods in Biology, Cambridge University Press, New York.
4. Banfield B. W., Leduc Y., Esford L., Schubert K., Tufaro F. Sequential isolation of proteoglycan synthesis mutants by using herpes simplex virus as a selective agent: Evidence for a proteoglycan-independent virus entry pathway. J. Virol. 69:1995;3290-3298.
5. Cai W. H., Gu B., Person S. Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J. Virol. 62:1988;2596-2604.
6. Coen D. M. Acyclovir-resistant, pathogenic herpesviruses. Trends Microbiol. 2:1994;481-485.
7. Coen D. M. Resistance of herpes simplex virus to antiviral drugs. Curr. Opin. Infect. Dis. 8:1995;489-492.
8. Coen D. M. Antiviral drug resistance in herpes simplex virus. Adv. Exp. Med. Biol. 394:1996;49-57.
9. Corey L., Spear P. G. Infections with herpes simplex viruses (1). N. Engl. J. Med. 314:1986a;686-691.
10. Corey L., Spear P. G. Infections with herpes simplex viruses (2). N. Engl. J. Med. 314:1986b;749-757.
11. Desai P. J., Schaffer P. A., Minson A. C. Excretion of non-infectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes simplex virus type 1: Evidence that gH is essential for virion infectivity. J. Gen. Virol. 69:1988;1147-1156.
12. Devi-Rao G. B., Aguilar J. S., Rice M. K., Garza H. H. Jr., Bloom D. C., Hill J. M., Wagner E. K. Herpes simplex virus genome replication and transcription during induced reactivation in the rabbit eye. J. Virol. 71:1997;7039-7047.
13. Devi-Rao G. B., Bloom D. C., Stevens J. G., Wagner E. K. Herpes simplex virus type 1 DNA replication and gene expression during explant induced reactivation of latently infected murine sensory ganglia. J. Virol. 68:1994;1271-1282.
14. Dingwell K. S., Johnson D. C. The herpes simplex virus gE-gI complex facilitates cell-to-cell spread and binds to components of cell junctions. J. Virol. 72:1998;8933-8942.
15. Geraghty R. J., Krummenacher C., Cohen G. H., Eisenberg R. J., Spear P. G. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science. 280:1998;1618-1620.
16. Gruenheid S., Gatzke L., Meadows H., Tufaro F. Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans. J. Virol. 67:1993;93-100.
17. Herold B. C., Visalli R. J., Susmarski N., Brandt C. R., Spear P. G. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J. Gen. Virol. 75:1994;1211-1222.
18. Herold B. C., WuDunn D., Soltys N., Spear P. G. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65:1991;1090-1098.
19. Hochberg E., Becker Y. Adsorption, penetration and uncoating of herpes simplex virus. J. Gen. Virol. 2:1968;231-241.
20. Huang A., Wagner R. R. Penetration of herpes simplex virus into human epidermoid cells. Proc. Soc. Exp. Biol. Med. 116:1964;863-869.
21. L. J. Virol. 67:1993;5109-5116.
22. Huang C.-J., Rice M. K., Devi-Rao G. B., Wagner E. K. The activity of the pseudorabies virus latency-associated transcript promoter is dependent on its genomic location in herpes simplex virus recombinants as well as on the type of cell infected. J. Virol. 68:1994;1972-1976.
23. Hutchinson L., Browne H., Wargent V., Davis-Poynter N., Primorac S., Goldsmith K., Minson A. C., Johnson D. C. A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. J. Virol. 66:1992;2240-2250.
24. Immergluck L. C., Domowicz M. S., Schwartz N. B., Herold B. C. Viral and cellular requirements for entry of herpes simplex virus type 1 into primary neuronal cells. J. Gen. Virol. 79:1998;549-559.
25. Jackson R. L., Busch S. J., Cardin A. D. Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes. Physiol. Rev. 71:1991;481-539.
26. Laquerre S., Argnani R., Anderson D. B., Zucchini S., Manservigi R., Glorioso J. C. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J. Virol. 72:1998;6119-6130.
27. Montgomery R. I., Warner M. S., Lum B. J., Spear P. G. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell. 87:1996;427-436.
28. Nahmias A., Kibrick S. Inhibitory effect of heparin on herpes simplex virus. J. Bacteriol. 87:1964;1060-1066.
29. Nakajima M., DeChavigny A., Johnson C. E., Hamada J., Stein C. A., Nicolson G. L. Suramin: A potent inhibitor of melanoma heparanase and invasion. J. Biol. Chem. 266:1991;9661-9666.
30. Nesburn, A. B. 1998, Report of the Corneal Disease Panel: Vision Research - A National Plan 1983-1987.
31. -. J. Virol. 72:1998;1411-1417.
32. Roop C., Hutchinson L., Johnson D. C. A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H. J. Virol. 67:1993;2285-2297.
33. Rotllán P., Rodríguez-Ferrer C. R., Asensio A. C., Oaknin S. Potent inhibition of specific diadenosine polyphosphate hydrolases by suramin. FEBS Lett. 429:1998;143-146.
34. Rusnati M., Tulipano G., Urbinati C., Tanghetti E., Giuliani R., Giacca M., Ciomei M., Corallini A., Presta M. The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists. J. Biol. Chem. 273:1998;16027-16037.
35. Shieh M.-T., WuDunn D., Montgomery R. I., Esko J. D., Spear P. G. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol. 116:1992;1273-1281.
36. Shieh M. T., Spear P. G. Herpesvirus-induced cell fusion that is dependent on cell surface heparan sulfate or soluble heparin. J. Virol. 68:1994;1224-1228.
37. Spector F. C., Liang L., Giordano H., Sivaraja M., Peterson M. G. Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex. J. Virol. 72:1998;6979-6987.
38. Takemoto K. K., Fabisch P. Inhibition of herpes virus by natural and synthetic acid polysaccarides. Proc. Soc. Exp. Biol. Med. 116:1964;140-144.
39. Voogd T. E., Vansterkenburg E. L. M., Wilting J., Jannsen L. H. M. Recent research on the biological activity of suramin. Pharmacol. Rev. 45:1993;177-203.
40. Wagner E. K., Bloom D. C. The experimental investigation of herpes simplex virus latency. Clin. Microbiol. Rev. 10:1997;419-443.
41. Wagner E. K., Petroski M. D., Pande N. T., Leiu P., Rice M. K. Analysis of factors influencing the kinetics of herpes simplex virus transcript expression utilizing recombinant virus. Methods. 1998.
42. WuDunn D., Spear P. G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:1989;52-58.